Literature DB >> 23155490

Door-to-balloon time in acute ST segment elevation myocardial infarction--further experience.

David J Fergusson1, Christian Spies, Robert A Hong, Catherine Young, Suzanne Rinn Beauvallet.   

Abstract

Early coronary reperfusion has been established as the optimal treatment for acute ST segment elevation myocardial infarction. A treatment protocol, previously described, has been designed to reduce delay in achieving recanalization of the culprit coronary artery. Over a period of about 4 years, Door-to-Balloon time has been analyzed for patients arriving in the Emergency Department with this condition. During that time the process was enhanced by the ability of ambulance personnel to transmit 12 lead EKG's from the field. Door-to-Balloon times have been analyzed and compared to the American College of Cardiology target of 90 minutes. After just over one year of gradually improving results, 100% compliance was achieved. From that time on, this was achieved during the period under consideration in 97% of cases.

Entities:  

Mesh:

Year:  2012        PMID: 23155490      PMCID: PMC3497916     

Source DB:  PubMed          Journal:  Hawaii J Med Public Health        ISSN: 2165-8242


  8 in total

1.  Thrombus aspiration during primary percutaneous coronary intervention.

Authors:  Tone Svilaas; Pieter J Vlaar; Iwan C van der Horst; Gilles F H Diercks; Bart J G L de Smet; Ad F M van den Heuvel; Rutger L Anthonio; Gillian A Jessurun; Eng-Shiong Tan; Albert J H Suurmeijer; Felix Zijlstra
Journal:  N Engl J Med       Date:  2008-02-07       Impact factor: 91.245

2.  Heparin plus a glycoprotein IIb/IIIa inhibitor versus bivalirudin monotherapy and paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction (HORIZONS-AMI): final 3-year results from a multicentre, randomised controlled trial.

Authors:  Gregg W Stone; Bernhard Witzenbichler; Giulio Guagliumi; Jan Z Peruga; Bruce R Brodie; Dariusz Dudek; Ran Kornowski; Franz Hartmann; Bernard J Gersh; Stuart J Pocock; George Dangas; S Chiu Wong; Martin Fahy; Helen Parise; Roxana Mehran
Journal:  Lancet       Date:  2011-06-12       Impact factor: 79.321

3.  Quality measure study: progress in reducing the door-to-balloon time in patients with ST-segment elevation myocardial infarction.

Authors:  Katsufumi Nishida; Sean K Hirota; Todd B Seto; Daniel C Smith; Cathy Young; Wanda Muranaka; Suzanne Beauvallet; David Fergusson
Journal:  Hawaii Med J       Date:  2010-10

4.  Strategies for reducing the door-to-balloon time in acute myocardial infarction.

Authors:  Elizabeth H Bradley; Jeph Herrin; Yongfei Wang; Barbara A Barton; Tashonna R Webster; Jennifer A Mattera; Sarah A Roumanis; Jeptha P Curtis; Brahmajee K Nallamothu; David J Magid; Robert L McNamara; Janet Parkosewich; Jerod M Loeb; Harlan M Krumholz
Journal:  N Engl J Med       Date:  2006-11-13       Impact factor: 91.245

5.  Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial.

Authors:  Sanjit S Jolly; Salim Yusuf; John Cairns; Kari Niemelä; Denis Xavier; Petr Widimsky; Andrzej Budaj; Matti Niemelä; Vicent Valentin; Basil S Lewis; Alvaro Avezum; Philippe Gabriel Steg; Sunil V Rao; Peggy Gao; Rizwan Afzal; Campbell D Joyner; Susan Chrolavicius; Shamir R Mehta
Journal:  Lancet       Date:  2011-04-04       Impact factor: 79.321

6.  ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1999 guidelines for the management of patients with acute myocardial infarction).

Authors:  Elliott M Antman; Daniel T Anbe; Paul Wayne Armstrong; Eric R Bates; Lee A Green; Mary Hand; Judith S Hochman; Harlan M Krumholz; Frederick G Kushner; Gervasio A Lamas; Charles J Mullany; Joseph P Ornato; David L Pearle; Michael A Sloan; Sidney C Smith
Journal:  J Am Coll Cardiol       Date:  2004-08-04       Impact factor: 24.094

7.  Ticagrelor versus clopidogrel in patients with acute coronary syndromes.

Authors:  Lars Wallentin; Richard C Becker; Andrzej Budaj; Christopher P Cannon; Håkan Emanuelsson; Claes Held; Jay Horrow; Steen Husted; Stefan James; Hugo Katus; Kenneth W Mahaffey; Benjamin M Scirica; Allan Skene; Philippe Gabriel Steg; Robert F Storey; Robert A Harrington; Anneli Freij; Mona Thorsén
Journal:  N Engl J Med       Date:  2009-08-30       Impact factor: 91.245

8.  Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial.

Authors:  Gilles Montalescot; Stephen D Wiviott; Eugene Braunwald; Sabina A Murphy; C Michael Gibson; Carolyn H McCabe; Elliott M Antman
Journal:  Lancet       Date:  2009-02-28       Impact factor: 79.321

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.